Novartis Venture Fund
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Relation
11 Dec 2025
Relation secures £40m in strategic backing from Novartis to advance drug discovery for atopic diseases
Relation develops an AI-driven drug discovery platform that combines human data and experimental systems to identify and validate new therapeutic targets for immune-related diseases.
NRG Therapeutics
8 Sept 2025
NRG Therapeutics lands £50m Series B led by SV Health Investors to advance neurodegenerative disease therapies
NRG Therapeutics develops oral small-molecule drugs targeting mitochondrial dysfunction, aiming to slow or halt neurodegenerative diseases such as ALS and Parkinson’s through disease-modifying treatments.
Novartis Venture Fund
- 2(12 months)
- nvfund.com
- Update Information
More venture news
- 11 Feb 2026
AMPLYAMPLY Discovery secures strategic investment from Keeps Biomed for its AI-led oncology drug discovery solution
StrategicLife Sciences - 1 Oct 2024
BMLLBMLL secures £16m strategic investment led by Optiver to supercharge growth
StrategicFintech - 8 Apr 2025
YonderYonder secures strategic cheque from NatWest to scale lifestyle credit card platform for millennials and expats
StrategicFintech
